Prestige Consumer Healthcare share price logo

Prestige Consumer Healthcare

NYSE: PBH

Mid Cap

$43.67

+0.69

(+1.61%)

as on

Prestige Consumer Healthcare Stock Performance

as on November 10, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $42.66
    $43.77
    downward going graph

    2.31%

    Downside

    0.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $41.77
    $71.07
    downward going graph

    4.35%

    Downside

    62.74%

    Upside

    downward going graph

Prestige Consumer Healthcare share price movements today

Previous Close
$42.98
Open
$43.47
Volume
405.3K
Market Cap
$2.0B
Day's Low - High
$42.66 - $43.77
52 Week Low - High
$41.77 - $71.07

Prestige Consumer Healthcare Historical Returns

1 Month Return
-9.45 %
3 Month Return
-17.6 %
1 Year Return
-27.77 %
3 Year Return
-24.3 %
5 Year Return
-29.68 %

Prestige Consumer Healthcare Stock Fundamentals & Key Indicators

Check Prestige Consumer Healthcare market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

3.26

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.38%

PE Ratio (TTM)

13.18

Industry PE ratio

22.29

PEG Ratio

-0.67

EBITDA

315.3M

Revenue (TTM)

1.2B

Profit Margin

52.01%

Return On Equity TTM

8.19%

Prestige Consumer Healthcare vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Prestige Consumer Healthcare with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.0B-29.68%13.1852.01%0.00%
Buy$45.0BNA68.5247.54%1.00%
StrongBuy$23.9B187.63%19.6886.34%0.00%
Buy$22.8B40.92%-37.5735.22%2.41%
Buy$39.8BNA18.6865.57%1.36%

Stock Returns calculator for Prestige Consumer Healthcare Stock including INR - Dollar returns

The Prestige Consumer Healthcare stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Prestige Consumer Healthcare investment value today

Current value as on today

₹76,480

Returns

-₹23,520

(-23.52%)

Returns from Prestige Consumer Healthcare Stock

-₹27,770 (-27.77%)

Dollar Impact

₹4,251 (+4.25%)

Analyst Recommendation on Prestige Consumer Healthcare Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Prestige Consumer Healthcare. Average target price of $66.6

Prestige Consumer Healthcare Share Price Target

Get share price movements and forecasts by analysts on Prestige Consumer Healthcare.

What analysts predicted

34.43%UPSIDE

Target Price

$66.6

Current Price

$43.67

Analyzed by

1 Analysts

High

$70

Target

$66.60

Low

$70

Prestige Consumer Healthcare target price $66.6, a slight upside of 34.43% compared to current price of $43.67. According to 1 analysts rating.

Indian Investors' Interest in Prestige Consumer Healthcare Stock

Search interest for Prestige Consumer Healthcare Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-62% versus previous 30 day period

Prestige Consumer Healthcare Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
267
283
290
296
249
274
283
281
265
336
Gross Profit
146
157
161
175
135
154
157
140
136
172
Operating Income
72
84
91
88
71
79
82
75
52
80
EBITDA
79
91
98
91
79
86
80
84
61
89
Interest Expense
13
12
11
10
10
10
10
11
13
30
Depreciation
8
7
6
7
7
7
7
8
8
11
Income Before Tax
58
71
80
73
61
69
61
64
38
47
Income Tax Expense
9
17
19
23
14
26
15
10
9
22
Net Income
49
54
61
50
47
42
46
53
29
25
Net Profit Margin
54.66%
55.50%
55.47%
59.21%
54.16%
56.21%
55.52%
50.02%
51.25%
51.30%

Prestige Consumer Healthcare Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
882
1,041
975
963
943
1,086
1,127
1,125
1,137
1,088
Gross Profit
500
576
555
552
547
620
625
624
634
574
Operating Income
205
215
67
291
297
329
-22
342
336
309
EBITDA
304
355
98
316
316
358
7
373
361
331
Interest Expense
93
106
105
96
82
64
69
67
47
42
Depreciation
25
33
31
28
30
32
32
30
30
31
Income Before Tax
110
107
-38
191
204
262
-93
276
284
257
Income Tax Expense
41
-232
-2
48
39
57
-11
66
69
67
Net Income
69
339
-35
142
164
205
-82
209
214
190
Net Profit Margin
56.72%
55.37%
56.94%
57.34%
58.03%
57.11%
55.45%
55.49%
55.76%
52.78%

Prestige Consumer Healthcare Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
49
54
61
50
47
42
46
53
29
25
Operating Cash Flow
54
69
65
61
79
57
78
42
70
37
Investing Cash Flow
-2
-2
-9
-3
-1
-2
-128
-3
-1,063
-138
Financing Cash Flow
-65
-51
-53
-11
-36
-74
-6
-38
1,018
58
Change in Cash
-12
17
0
47
41
-20
-56
1
25
-42

Prestige Consumer Healthcare Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
69
339
-35
142
164
205
-82
209
214
190
Operating Cash Flow
147
210
189
217
235
259
229
248
251
257
Investing Cash Flow
-694
-11
55
-16
-22
-256
-11
-20
-17
-136
Financing Cash Flow
561
-208
-249
-131
-279
-7
-185
-241
-182
-156
Change in Cash
14
-9
-5
67
-62
-5
31
-12
51
-34

Global Institutional Holdings in Prestige Consumer Healthcare

Check out the Institutions with significant holdings in Prestige Consumer Healthcare.

Funds
Holdings
BlackRock, Inc.
16.52%
iShares
11.50%
John Rogers
10.27%
Vanguard
9.73%
VANGUARD INDEX FUNDS
8.08%

Prestige Consumer Healthcare News & Key Events

  • img

    Today's Timeline - 05 November

    Thu, 04:51 PM

    -

    Prestige Consumer reports Q2 adjusted EPS of $1.13, exceeding consensus of $1.07, with revenue of $336.3M surpassing expectations.

    Thu, 04:56 PM

    -

    Prestige Consumer lowers FY27 adjusted EPS outlook to $4.48-$4.55, citing Clear Eyes production variability affecting revenue.

    Thu, 05:13 PM

    -

    Prestige Consumer reports fiscal 2027 Q2 results, with revenue up 22.7% and adjusted EPS rising to $1.13.

Insights on Prestige Consumer Healthcare

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 265.70M → 336.30M (in $), with an average increase of 21.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 101.5% return, outperforming this stock by 129.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 122.7% return, outperforming this stock by 147.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 53.92M → 25.29M (in $), with an average decrease of 29.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PBH stock has moved down by -11.8%

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
OrganisationPrestige Consumer Healthcare
Headquarters660 White Plains Road, Tarrytown, NY, 10591, US
IndustryMedical - Pharmaceuticals
CEORonald Lombardi

Key Management of Prestige Consumer Healthcare

Name

Title

Mr. Philip David Terpolilli C.F.A.

Director of Investor Relations

Dean Siegal

Director of Communications

Mr. Jose Luis Rosado

Senior Vice President of Quality & Regulatory Affairs

Mr. Ronald M. Lombardi CPA

Chairman, President & CEO

Ms. Christine Sacco CPA

CFO & COO

Mr. William C. P'Pool J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Adel Mekhail

Executive Vice President of Marketing & Sales

FAQs

What is Prestige Consumer Healthcare share price today?

Prestige Consumer Healthcare share price today is $43.67 as on at the close of the market. Prestige Consumer Healthcare share today touched a day high of $43.77 and a low of $42.66.

What is the 52 week high and 52 week low for Prestige Consumer Healthcare share?

Prestige Consumer Healthcare share touched a 52 week high of $71.07 on and a 52 week low of $41.77 on . Prestige Consumer Healthcare stock price today i.e. is closed at $43.67,which is 38.55% down from its 52 week high and 4.55% up from its 52 week low.

What is Prestige Consumer Healthcare's market capitalisation today?

Prestige Consumer Healthcare market capitalisation is $0.00T as on .

How to invest in Prestige Consumer Healthcare Stock (PBH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Prestige Consumer Healthcare on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Prestige Consumer Healthcare Stock (PBH) from India?

Indian investors can start investing in Prestige Consumer Healthcare (PBH) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Prestige Consumer Healthcare stock (as per the Rupee-Dollar exchange rate as on ). Based on Prestige Consumer Healthcare share’s latest price of $43.67 as on November 10, 2026 at 8:46 am IST, you will get 0.2290 shares of Prestige Consumer Healthcare. Learn more about fractional shares .

What are the returns that Prestige Consumer Healthcare has given to Indian investors in the last 5 years?

Prestige Consumer Healthcare stock has given -29.68% share price returns and 26.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?